Skip to content
value.today

Denali Medical Inc.

🇺🇸 Plymouth, Minnesota, USABiotechnologyFounded 2006
Total raised
$51 M
6 rounds on record
Latest round
$8 M
Jul 2016
First round on record
Aug 2009
Today
Private
No later event on record

Funding rounds

6 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Denali Medical Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jul 2016$8 MNo. 6$2 to $10 million

Denali Medical Inc.: Raise no. 6, Jul 2016

Investors in this round

13 investors had bought by the notice of Aug 9, 2016: 13 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$8 M of $8 M offered
Smallest investment taken
$1
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Martha Shadan · Executive Officer, Director
  • Thomas Westling · Executive Officer, Director
  • Ali Behbahani · Director
  • Fouad Azzam · Director
  • J. Albert Graf · Director
  • Kevin Sidow · Director
  • Michael DeMane · Director
  • Scott Weiner · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Excludes standard compensation for officers.”

Signed by Martha Shadan, President and CEO. Newest notice filed Aug 9, 2016. Read the notice at the SEC.

equitySEC
Jun 2014$22 MNo. 5$10 to $50 million

Denali Medical Inc.: Raise no. 5, Jun 2014

Investors in this round

14 investors had bought by the notice of Jul 10, 2014: 14 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$22 M of $22 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Craig Van Kampen · Executive Officer
  • Martha Shadan · Executive Officer, Director
  • Randy Nuernberg · Executive Officer
  • Thomas Westling · Executive Officer, Director
  • Albert Graf · Director
  • Ali Behbahani · Director
  • Fouad Azzam · Director
  • John Nehra · Director
  • Kevin Sidow · Director
  • Michael DeMane · Director
  • Scott Weiner · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Excludes normal compensation for officers.”

Signed by Martha Shadan, President and Chief Executive Officer. Newest notice filed Jul 10, 2014. Read the notice at the SEC.

equitySEC
May 2013$6 MNo. 4$2 to $10 million

Denali Medical Inc.: Raise no. 4, May 2013

Investors in this round

9 investors had bought by the notice of Jun 5, 2013: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $6 M offered
Smallest investment taken
$1
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Craig Jay Van Kampen · Executive Officer
  • Jeff Jay Sims · Executive Officer
  • Randy Jay Nuernberg · Executive Officer
  • Thomas A Westling · Executive Officer, Director
  • Albert Jay Graf · Director
  • Ali Jay Behbahani · Director
  • John A Nehra · Director
  • Kevin Jay Sidow · Director
  • Michael Jay DeMane · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Excludes normal compensation for officers.”

Signed by Thomas A. Westling, President and Chief Executive Officer. Newest notice filed Jun 5, 2013. Read the notice at the SEC.

debt, optionsSEC
Apr 2011$10 MNo. 3$10 to $50 million

Denali Medical Inc.: Raise no. 3, Apr 2011

Investors in this round

1 investor had bought by the notice of Apr 14, 2011: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $15 M offered; $5 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Charles L. Euteneuer · Executive Officer
  • Craig A. Van Kampen · Executive Officer
  • James R. Ness · Executive Officer
  • Jeff L. Sims · Executive Officer
  • Thomas A. Westling · Executive Officer, Director
  • Albert Jay Graf · Director
  • Ali Jay Behbahani · Director
  • John R. Nehra · Director
  • Michael R. DeMane · Director
  • Thomas R. Hektner · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Excludes normal compensation to officers.”

Signed by Thomas A. Westling, President and Chief Executive Officer. Newest notice filed Apr 14, 2011. Read the notice at the SEC.

equitySEC
Mar 2010$4 MNo. 2$2 to $10 million

Denali Medical Inc.: Raise no. 2, Mar 2010

Investors in this round

4 investors had bought by the notice of Mar 18, 2010: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $4 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Charles L. Euteneuer · Executive Officer
  • Craig A. Van Kampen · Executive Officer
  • D. William Kaufman · Executive Officer
  • James R. Ness · Executive Officer
  • Thomas A. Westling · Executive Officer, Director
  • Albert Jay Graf · Director
  • Ali Jay Behbahani · Director
  • John William Nehra · Director
  • Michael William DeMane · Director
  • Thomas R. Hektner · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Excludes normal compensation to officers.”

Signed by Thomas A. Westling, President and Chief Executive Officer. Newest notice filed Mar 18, 2010. Read the notice at the SEC.

equitySEC
Aug 2009$2 MNo. 1$2 to $10 million

Denali Medical Inc.: Raise no. 1, Aug 2009

Investors in this round

6 investors had bought by the notice of Sep 4, 2009: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • D. William Kaufman · Executive Officer
  • James Ness · Executive Officer
  • Thomas R. Hektner · Executive Officer, Director
  • Albert Jay Graf · Director
  • John Nehra · Director
  • Michael DeMane · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Excludes normal compensation to officers.”

Signed by Thomas Hektner, President and Chief Executive Officer. Newest notice filed Sep 4, 2009. Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Denali Medical Inc. chose not to state its revenue in its newest notice of a funding round (Aug 2016).

    SEC Form D · Aug 2016

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Aug 2016

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Denali Medical Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Denali Medical Inc.
NameRoleNamed in
Martha ShadanExecutive officerAug 2016
Thomas WestlingExecutive officerAug 2016
Craig Van KampenExecutive officerJul 2014
Randy NuernbergExecutive officerJul 2014
Craig Jay Van KampenExecutive officerJun 2013
Jeff Jay SimsExecutive officerJun 2013
Randy Jay NuernbergExecutive officerJun 2013
Thomas A WestlingExecutive officerJun 2013
Charles L. EuteneuerExecutive officerApr 2011
Craig A. Van KampenExecutive officerApr 2011
James R. NessExecutive officerApr 2011
Jeff L. SimsExecutive officerApr 2011
Thomas A. WestlingExecutive officerApr 2011
D. William KaufmanExecutive officerMar 2010
James NessExecutive officerSep 2009
Thomas R. HektnerExecutive officerSep 2009
Ali BehbahaniDirectorAug 2016
Fouad AzzamDirectorAug 2016
J. Albert GrafDirectorAug 2016
Kevin SidowDirectorAug 2016
Martha ShadanDirectorAug 2016
Michael DeManeDirectorAug 2016
Scott WeinerDirectorAug 2016
Thomas WestlingDirectorAug 2016
Albert GrafDirectorJul 2014
John NehraDirectorJul 2014
Albert Jay GrafDirectorJun 2013
Ali Jay BehbahaniDirectorJun 2013
John A NehraDirectorJun 2013
Kevin Jay SidowDirectorJun 2013
Michael Jay DeManeDirectorJun 2013
Thomas A WestlingDirectorJun 2013
John R. NehraDirectorApr 2011
Michael R. DeManeDirectorApr 2011
Thomas A. WestlingDirectorApr 2011
Thomas R. HektnerDirectorApr 2011
John William NehraDirectorMar 2010
Michael William DeManeDirectorMar 2010